Ortho Clinical Diagnostics, Raritan, NJ, has announced that it has received a CE mark signifying conformance to applicable European Union regulatory requirements for the company’s Vitros XT MicroSlide, a new multitest technology that enables labs to run two tests simultaneously.

The new XT MicroSlide is powered by digital chemistry, an optics technology that gleans significantly more information from each test than before, improving performance, saving time and space in the lab, and increasing productivity, with less patient sample required for testing. This is an important advantage for vulnerable patients or those with venous access issues.


Heidi Casaletto, Ortho Clinical Diagnostics.

“Vitros XT MicroSlides improve performance and productivity by delivering high-quality results and higher throughput without requiring more lab space,” says Heidi Casaletto, head of portfolio strategy and marketing at Ortho. “Having the capability to perform two tests on one slide offers several key advantages to the lab and to the patient—especially those with venous access issues—by requiring a smaller sample volume for testing and enabling more timely reporting.”

Key features and benefits of the XT MicroSlide include:

  • Digital chemistry. Advanced digital imaging optics technology that gleans significantly more information from each test than before, improving performance and enabling powerful data analysis.
  • Reliably high-quality result. Enables labs to consistently and efficiently deliver accurate and reliable results.
  • Increased productivity and efficiency. Simultaneously performs two tests that are commonly ordered together from a single small blood sample. This improves lab productivity and turnaround time, while simplifying inventory management and optimizing storage space.
Aldunate Ortega

Jorge Aldunate Ortega, MD, RedSalud.

“The Ortho Vitros XT MicroSlide is a great technological leap, with digital chemistry signifying a true revolution in the pursuit of consistently reliable and accurate clinical diagnoses,” notes Jorge Aldunate Ortega, MD, clinical laboratory manager of RedSalud in Chile. “This technology reinforces Ortho as the trusted leader in the field of chemistry and immunodiagnostics.”

The products available with the Vitros  XT 7600 integrated system became available for purchase in March 2019. The product is currently available for purchase in numerous countries, including Australia, Chile, France, Germany, Hong Kong, Iceland, Italy, Liechtenstein, New Zealand, Norway, Spain, Switzerland, and the UK.

For further information, visit  Ortho Clinical Diagnostics.

Featured image: The Vitros XT MicroSlide (right) can perform two tests simultaneously, a significant advance over the previous generation single-test Microslide (left) from Ortho Clinical Diagnostics.